- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- July 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2021
Global
From €3808EUR$3,990USD£3,191GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2022
- 37 Pages
Global
From €1909EUR$2,000USD£1,599GBP
Anal Fissure Drugs are a type of Gastrointestinal Drug used to treat anal fissures, which are small tears in the lining of the anus. These drugs are typically used to reduce pain and spasm, as well as to promote healing of the fissure. Commonly used Anal Fissure Drugs include topical anesthetics, topical nitrates, and topical calcium channel blockers. These drugs are typically applied directly to the affected area, and may be used in combination with other treatments such as dietary changes and stool softeners.
The Anal Fissure Drug market is a subset of the larger Gastrointestinal Drug market, which is composed of a variety of drugs used to treat a range of gastrointestinal conditions. This market is highly competitive, with many companies offering a variety of products. Some of the major players in the Anal Fissure Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more